- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fujimori named to lead GEMS Asia
GE has shifted its executive lineup in Asia, promoting Goran Malm to president of GE Asia-Pacific and naming Yoshiaki Fujimori to assume Malm's position as president and CEO of GE Medical Systems Asia. Fujimori was previously general manager of global
GE has shifted its executive lineup in Asia, promoting Goran Malm to president of GE Asia-Pacific and naming Yoshiaki Fujimori to assume Malm's position as president and CEO of GE Medical Systems Asia. Fujimori was previously general manager of global MRI, nuclear medicine, and PET at GE Medical Systems in Milwaukee.
Malm is credited with orchestrating the expansion of GEMS in a broad geographic region that ranges from Japan to Australia to India. In his new capacity, Malm will lead GE's international activities in the Asia-Pacific region.
Fujimori credited the MRI product development group's ability to bring new systems to market as a key to his elevation. This is Fujimori's second Asian tour of duty: He was manager of business development for GE Medical Systems Asia in 1990 when he was transferred to Milwaukee as general manager of nuclear medicine. In 1992, he was named manager of CT and radiation therapy. In February 1996, the company announced his appointment as global general manager of MRI operations.
Succeeding Fujimori as general manager of global MRI is Gene Saragnese, who was transferred to Milwaukee in late 1995 as manager of MR engineering. Fujimori's managerial duties over nuclear medicine and PET in Milwaukee were delegated to Sharon Banaszewski, who was promoted to general manager of the nuclear medicine/PET group.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
